Information Library
Connect with investigators, regulators and physicians - Phase IIIB/IV
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
ASCO 2010 Annual Meeting
June 4 - June 8, 2010
Exhibit Dates: June 5 - 7, 2010 Exhibitor Booth Number: 2053 -
Incremental Cost of Otitis Media Among Children in the United States
June 25, 2009
Using a nationally representative data source, the study estimates the medical cost of treating otitis media among children in the US. The costs are estimated at $2 billion in 2005. -
Patient Registries: A Taxonomy for the Design, Development and Implementation
June 25, 2009
Recommendations from the ISPOR Patient Registry Classification, Strategy & Design Working Group, Team 2, for developing standard language for the characterization, classification, strategy, design, and execution of patient registries to generate data for outcomes research purposes. -
Early phase strategies
June 15, 2009
Web cast about Early Phase Strategies. -
Oversight Group Management Services
April 16, 2009
Quintiles provides a high level of experience, expertise and customer service to the entire clinical trial process. This is especially true for the oversight group management service, known as CEVA. -
Risk Mitigation Programs
April 16, 2009
Risk mitigation measures can help keep valuable drugs on the market, even when their safety profile includes adverse events that might negatively affect the benefit risk balance. -
Risk Assessment & Strategy
April 16, 2009
Quintiles benefit risk analysis can help you anticipate potential regulatory concerns and highlight the benefit side of your drug’s benefit risk profile. -
Phase IIIb/IV Studies
April 16, 2009
New, more efficient delivery models help meet the increasing demands of Phase IIIB/IV Studies. -
Late Phase and Safety Services
April 10, 2009
Recent and pending regulatory changes have created an atmosphere of watchful waiting throughout the industry. While it may seem premature to initiate post-marketing studies to collect more “intelligent” safety data, Quintiles Late Phase & Safety Services anticipates that the need for expanded studies will soon spread. -
Accelerating a Trial Delayed by Slow Approvals
March 27, 2009
Intense remote monitoring by project coordination center quickly speeds up recruitment
Page 1 of 1 (10 items)